TOP TIERMARKET NEWSWIRE
News & sentiment

HALOZYME THERAPEUTIC (HALO) — News & AI sentiment

HALOZYME THERAPEUTIC (HALO) news roundup. 2 stories in the last 24 hours, 6 in the past week, 16 over 30 days. Average 24-hour sentiment is 62.5/100 — bullish-leaning (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 6 sales totalling $7.7M — net selling of $7.7M. US House Periodic Transaction Reports (90-day window): 1 purchase (~$8K) and 0 sales (~$0). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
2
avg sentiment 62.5/100
7d stories
6
avg sentiment 62.3/100
30d stories
16
avg sentiment 59.6/100
Insider net (90d)
$7.7M
0 buys · 6 sells
Congress (90d)
1
1 buys · 0 sells

Latest stories on HALO

14h ago
16h ago
Four Stocks Hit New Highs Amid Tech Meltdown
Investors.com63 · neutralgeneral
6d ago
Four Stocks Hit New Highs Amid Tech Meltdown
Investors.com63 · neutralgeneral
6d ago
7d ago
Jul 22
Benchmark reiterates Halozyme stock Buy rating on Incyte deal
Investing.com Analyst Ratings61 · neutralanalyst
Jul 21
H.C. Wainwright reiterates Incyte stock rating on Halozyme deal
Investing.com Analyst Ratings56 · neutralanalyst
Jul 21
Jul 20
Jul 20
Jul 20
Jul 15
Jul 2
Jul 2
Jun 30
Jun 30
Jun 23
Halozyme Therapeutics: Royalty King
Seeking Alpha67 · bullishanalyst
May 20
May 12
May 11
May 7
Open HALO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →